T

Trajan Group Holdings Ltd
ASX:TRJ

Watchlist Manager
Trajan Group Holdings Ltd
ASX:TRJ
Watchlist
Price: 1.095 AUD Market Closed
Market Cap: 166.7m AUD
Have any thoughts about
Trajan Group Holdings Ltd?
Write Note

Trajan Group Holdings Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Trajan Group Holdings Ltd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
T
Trajan Group Holdings Ltd
ASX:TRJ
Total Liabilities
AU$85.1m
CAGR 3-Years
37%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Anteotech Ltd
ASX:ADO
Total Liabilities
AU$4.1m
CAGR 3-Years
17%
CAGR 5-Years
50%
CAGR 10-Years
22%
Proteomics International Laboratories Ltd
ASX:PIQ
Total Liabilities
AU$1.5m
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Total Liabilities
AU$18.3m
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Genetic Signatures Ltd
ASX:GSS
Total Liabilities
AU$6.2m
CAGR 3-Years
10%
CAGR 5-Years
32%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Total Liabilities
AU$4.2m
CAGR 3-Years
30%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Trajan Group Holdings Ltd
Glance View

Market Cap
166.7m AUD
Industry
Life Sciences Tools & Services

Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.

TRJ Intrinsic Value
2.868 AUD
Undervaluation 62%
Intrinsic Value
Price
T

See Also

What is Trajan Group Holdings Ltd's Total Liabilities?
Total Liabilities
85.1m AUD

Based on the financial report for Jun 30, 2024, Trajan Group Holdings Ltd's Total Liabilities amounts to 85.1m AUD.

What is Trajan Group Holdings Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
28%

Over the last year, the Total Liabilities growth was -14%. The average annual Total Liabilities growth rates for Trajan Group Holdings Ltd have been 37% over the past three years , 28% over the past five years .

Back to Top